IRMD analyst estimates

iRadimed (IRMD) analyst ratings, the average price target and its range, and every firm's latest call.

IRMD analyst ratings and price targets

DateFirmCallTarget
Feb 11, 2026Lake StreetiRadimed price target raised to $120 from $100 at Lake Street$120.00
Feb 10, 2026Roth CapitaliRadimed price target raised to $120 from $98 at Roth Capital$120.00
Nov 3, 2025Lake StreetiRadimed price target raised to $100 from $75 at Lake Street$100.00
Nov 3, 2025Roth CapitaliRadimed price target raised to $98 from $90 at Roth Capital$98.00
Oct 31, 2025Roth CapitaliRadimed resumed with a Buy at Roth Capital$90.00
Aug 2, 2024Roth CapitaliRadimed price target lowered to $60 from $65 at Roth MKM$60.00
Jun 17, 2024Loop Capital MarketsLake Street Capital Markets Reiterates Buy Rating on IRadimed Corp (IRMD)$60.00

Updated 2026-11-07 11:52 UTC